Rotary kinetic fluid motors or pumps – With control means responsive to non-cyclic condition... – By shaft speed or torque responsive means
Reexamination Certificate
2009-05-26
2011-11-15
Li, Bao (Department: 1648)
Rotary kinetic fluid motors or pumps
With control means responsive to non-cyclic condition...
By shaft speed or torque responsive means
C424S228100, C435S320100
Reexamination Certificate
active
08057162
ABSTRACT:
The invention relates to a peptidic compound containing a polyprotein NS3/NS4 of a hepatitis C virus and a polypeptide NS5b of hepatitis C virus. Said invention also relates to expression vectors such as adenovirus and poxvirus in which nucleic sequences coding for the polyprotein NS3/NS4 and the polypeptide NS5b. The inventive compound can be used for a therapeutic application.
REFERENCES:
patent: 6312889 (2001-11-01), Houghton et al.
patent: 6562346 (2003-05-01), Paliard et al.
patent: 6986892 (2006-01-01), Coit et al.
patent: 7052696 (2006-05-01), Fields et al.
patent: 7285539 (2007-10-01), Paliard et al.
patent: 7695960 (2010-04-01), Inchauspe et al.
patent: 2007/0269460 (2007-11-01), Inchauspe et al.
patent: WO 01/30812 (2001-05-01), None
Pancholi et al., “DNA Immunication with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1—Transgenic Mice,”Journal of Virology, 2003, vol. 77, No. 1, pp. 382-390, American Society for Microbiology, Washington, D.C.
Cho et al., “Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA Immunication,”Vaccine, 1999, vol. 17, pp. 1136-1144, Elsevier Science, Amsterdam, Holland.
Clarke et al., “Molecular virology of hepatitis C virus,”Journal of General Virology, 1997, vol. 78, pp. 2397-2410, American Society for Microbiology, Washington, D.C.
Inchauspe et al., “Development of a hepatitis C virus vaccine,”Clin. Liver Dis., 2003, vol. 7, pp. 243-259, Elsevier. Amsterdam, Holland.
Hsu et al., “Prospects for a Hepatitis C Virus Vaccine,”Clin. Liver Dis., 1999, vol. 3, pp. 901-915, Elsevier. Amsterdam, Holland.
Purcell et al., “The Hepatitis C Virus: Overview,”Hepatology, Sep. 1997, vol. 26, pp. 11A-14A, American Association for the Study of Liver Diseases, Alexandria, Virginia.
Krieger et al., “Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations,”J. Virol., 2001, vol. 75, No. 10, pp. 4614-4624, American Society for Microbiology, Washington, D.C.
Hadziyannis et al., “Peginterferon-α2a (40 kDa) for chronic hepatitis C,”Expert Opinion on Pharmacotherapy, Apr. 2003, vol. 4, No. 4, pp. 541-551, Informa Healthcare, London, England.
Paul et al., “Tumor gene therapy by MVA-mediated expression of T-cell-stimulating anitbodies,”Cancer Gene Therapy, 2002, vol. 9, pp. 470-477, Nature Publishing Group, London, England.
Fournillier et al., “An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses,”Vaccine, 2007, vol. 25, pp. 7339-7353, Elsevier Ltd., Amsterdam, Holland.
Abraham Jean-Daniel
Dimitrova-Tchomakov Maria
Fournillier Anne
Inchauspe Genevieve
Parnot Marie
Buchanan & Ingersoll & Rooney PC
Institut National de la Sante et De La Recherche Medicale
Li Bao
Transgene S.A.
LandOfFree
Composition comprising the polyprotein NS3/NS4 and the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising the polyprotein NS3/NS4 and the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising the polyprotein NS3/NS4 and the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287763